Viewing nowCandesartan 16 mg (Candesartan Cilexetil)
Candesartan Cilexetil 16mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 200907796 · Notified 2009.10.29 · Insurance code 649805020
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
This medication is used to effectively manage blood pressure in patients with essential hypertension. It is also effective for heart failure patients with impaired left ventricular function who require additional treatment with ACE inhibitors or have poor tolerance. This helps to alleviate heart failure symptoms and improve cardiac function. Thus, it can be safely used for the management of hypertension and heart failure.
This medicine should be taken at the same time each day, with or without food. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled with this dose, other treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. Elderly: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: Administer an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, depending on the patient's tolerability. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Essential hypertension: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.
This medication poses a serious risk of harm to the fetus or newborn during pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used by individuals allergic to this medication or its components, pregnant or breastfeeding women, patients with severe liver dysfunction, or patients with hereditary angioedema. Caution is advised for the elderly, patients with hyperkalemia, patients with mild liver function impairment, and patients with heart valve disease or obstructive cardiomyopathy. Mild side effects such as dizziness, back pain, and respiratory infections may occur during this medication's usage, and in rare cases, severe allergic reactions, renal function impairment, or hypotension may occur, necessitating immediate consultation with healthcare providers if symptoms arise. Especially, patients with heart failure or compromised renal function should regularly monitor potassium levels and renal function for any abnormalities. Caution is required during driving or operating machinery due to potential dizziness or fatigue resulting from blood pressure reduction. Combining this medication with other antihypertensives or potassium-sparing diuretics may increase the risk of side effects, so consultation with a healthcare provider is necessary before use. Women who are pregnant or planning to become pregnant should not use this medication, and it is advisable to avoid use while breastfeeding. Safety and efficacy for children and adolescents have not been established, so usage is not recommended in these groups. In the case of overdose, symptoms may include hypotension, dizziness, and tachycardia; appropriate treatment should be sought immediately at a medical institution. This medication should be stored out of reach of children and should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius. Storing it this way ensures the medication's efficacy is safely maintained.
Round tablets with a convex face, light yellowish-pink in color.
30 tablets/bottle, 100 tablets/bottle, 30 tablets (10 tablets/PTP*3, for export)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCandesartan Cilexetil 16mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Yuhans Chemical Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Yuhan Corporation

Candesartan Cilexetil 32mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Jong Kun Dang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.